675 related articles for article (PubMed ID: 17522398)
21. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
Fink SP; Yamauchi M; Nishihara R; Jung S; Kuchiba A; Wu K; Cho E; Giovannucci E; Fuchs CS; Ogino S; Markowitz SD; Chan AT
Sci Transl Med; 2014 Apr; 6(233):233re2. PubMed ID: 24760190
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
Doherty GA; Murray FE
Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
[TBL] [Abstract][Full Text] [Related]
23. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
24. Aspirin, COX-2, and the risk of colorectal cancer.
Benelli R
N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17715417
[No Abstract] [Full Text] [Related]
25. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
26. Aspirin and the risk of colorectal cancer in women.
Giovannucci E; Egan KM; Hunter DJ; Stampfer MJ; Colditz GA; Willett WC; Speizer FE
N Engl J Med; 1995 Sep; 333(10):609-14. PubMed ID: 7637720
[TBL] [Abstract][Full Text] [Related]
27. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
Lin CC; Lai MS; Shau WY
Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
[TBL] [Abstract][Full Text] [Related]
28. Aspirin, COX-2, and the risk of colorectal cancer.
Murashige N; Kami M; Ikeda M
N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17717859
[No Abstract] [Full Text] [Related]
29. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Harris RE; Beebe-Donk J; Doss H; Burr Doss D
Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
[TBL] [Abstract][Full Text] [Related]
30. [Aspirin against cancer].
Mabro M; de Gramont A
Rev Med Interne; 2000 Mar; 21 Suppl 1():60s-67s. PubMed ID: 10763206
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of aspirin use and the risk for colorectal adenoma.
Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
[TBL] [Abstract][Full Text] [Related]
32. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S; Kaidi A; Williams AC; Paraskeva C
Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
[TBL] [Abstract][Full Text] [Related]
33. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
34. The prevention of colorectal cancer by aspirin use.
Giovannucci E
Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
[TBL] [Abstract][Full Text] [Related]
35. Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, Italy.
Ventura L; Miccinesi G; Barchielli A; Manneschi G; Puliti D; Mantellini P; Orso F; Zappa M
Eur J Cancer Prev; 2018 Mar; 27(2):134-139. PubMed ID: 27845951
[TBL] [Abstract][Full Text] [Related]
36. The role of COX-2 in intestinal cancer.
Williams C; Shattuck-Brandt RL; DuBois RN
Ann N Y Acad Sci; 1999; 889():72-83. PubMed ID: 10668484
[TBL] [Abstract][Full Text] [Related]
37. [Aspirin in the prevention of colorectal cancer].
Zubiaurre L; Bujanda Fernández de Pierola L
Gastroenterol Hepatol; 2011 May; 34(5):337-45. PubMed ID: 21435744
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 as a target for prevention of colorectal cancer.
Bertagnolli MM
Curr Oncol Rep; 1999; 1(2):173-8. PubMed ID: 11122816
[TBL] [Abstract][Full Text] [Related]
39. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
40. Exploring Differences in the Aspirin-Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Monroe KR; Haiman CA; Marchand LL
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):162-169. PubMed ID: 27765797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
